Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000318306-06-000025
Filing Date
2006-11-20
Accepted
2006-11-20 14:56:46
Documents
5
Period of Report
2006-11-20

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q r10q-700.txt 10-Q 120869
2 CEO CERTIFICATION r10q-701.txt EX-31.1 3630
3 CFO CERTIFICATION r10q-702.txt EX-31.2 3625
4 CEO CERTIFICATION r10q-703.txt EX-32.1 1853
5 CFO CERTIFICATION r10q-704.txt EX-32.2 1852
  Complete submission text file 0000318306-06-000025.txt   133527
Mailing Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207
Business Address 2600 N STEMMONS FRWY STE 176 DALLAS TX 75207 2149055100
ACCESS PHARMACEUTICALS INC (Filer) CIK: 0000318306 (see all company filings)

EIN.: 830221517 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-15771 | Film No.: 061229555
SIC: 2834 Pharmaceutical Preparations